25.Ischemic Pain in the Extremities and Raynaud's Phenomenon

Pain Practice

Volumn 11, Issue 5, 2011, Pages 483-491

  Devulder, Jacques ^a   van Suijlekom, Hans ^b   van Dongen, Robert ^c   Diwan, Sudhir ^d   Mekhail, Nagy ^e   Van Kleef, Maarten ^f   Huygen, Frank ^g  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CATHARINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Evidence based medicine; Ischemic pain; Raynaud's phenomenon

Indexed keywords

BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; NIFEDIPINE; PRAZOSIN; PROSTAGLANDIN SYNTHASE;

ACROCYANOSIS; ARTERIOSCLEROSIS; ARTICLE; BUERGER DISEASE; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; EXERCISE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; LIMB ISCHEMIA; LIMB PAIN; LIVEDO RETICULARIS; NAUSEA; OXYGEN SATURATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PROGNOSIS; RAYNAUD PHENOMENON; SMOKING; SPINAL CORD STIMULATION; SYMPATHECTOMY; VASCULARIZATION; VASOCONSTRICTION;

EID: 80052961594     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2011.00460.x     Document Type: Article

References (31)

1. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006;129:1.
2. van Kleef M, Mekhail N, van Zundert J. Evidence-based guidelines for interventional pain medicine according to clinical diagnoses. Pain Pract. 2009;9:247-251.
3. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev. 2005;3:CD004001.
4. Block JA, Sequeira W. Raynaud's phenomenon. Lancet. 2001;357:2042-2048.
5. Wigley FM. Clinical practice. Raynaud's Phenomenon. N Engl J Med. 2002;347:1001-1008.
6. Carpentier P, Sotger B, Poensin D, Maricq H. Incidence and natural history of Raynaud's phenomenon: a long-term follow-up (14 years) of a random sample from the general population. J Vasc Surg. 2006;44:1023-1028.
7. Mills JL Sr. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg. 2003;16:179-189.
8. Ting J, Fukshandsky M, Burton A. Treatment of refractory ischemic pain from chemotherapy-induced Taynaud's syndrome with spinal cord stimulation. Pain Practice. 2007;7(2):143-146.
9. Pope JE. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Drugs. 2007;67:517-525.
10. Cooke JP, Marshall JM. Mechanisms of Raynaud's disease. Vasc Med. 2005;10:293-307.
11. Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders.]. Helv Chir Acta. 1954;21:499-533.
12. Cross FW, Cotton LT. Chemical lumbar sympathectomy for ischemic rest pain. A randomized, prospective controlled clinical trial. Am J Surg. 1985;150:341-345.
13. Barnes RW, Baker WH, Shanik G, et al. Value of concomitant sympathectomy in aortoiliac reconstruction. Results of a prospective, randomized study. Arch Surg. 1977;112:1325-1330.
14. Fyfe T, Quin RO. Phenol sympathectomy in the treatment of intermittent claudication: a controlled clinical trail. Br J Surg. 1975;62:68-71.
15. Sanni A, Hamid A, Dunning J. Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularisation? Interact Cardiovasc Thorac Surg. 2005;4:478-483.
16. Repealer van Driel O, Van Bockel J, Van Schilfgarde R. Lumbar sympathectomy for severe lower limb ischaemia: results and analysis of factors influencing outcome. J Cardiovasc Surg. 1998;29:310-314.
17. Keane FB. Phenol lumbar sympathectomy for severe arterial occlusive disease in the elderly. Br J Surg. 1977;64:519-521.
18. Mashiah A, Soroker D, Pasik S, Mashiah T. Phenol lumbar sympathetic block in diabetic lower limb ischemia. J Cardiovasc Risk. 1995;2:467-469.
19. Barendse GA, Köke A, Kemler M. Neuromodulatie en TENS. In: Van Kleef M, Weber W, Winter F, Zuurmond W, eds. Handboek pijnbestrijding, Vol. ed. Leusden, Nederland: De Tijdstroom; 2000: 279-285.
20. Jivegard LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg. 1995;9:421-425.
21. Suy R, Gybels J, Van DH, Martin D, Van MR, Delaporte C. Spinal cord stimulation for ischaemic rest pain. The Belgian randomized study. In: Horschs S, Claeys L, eds. Spinal cord Stimulation: An Innovative Method in the Treatment of PVD, Vol. ed. Darmstadt: Steinhoff; 1994: 197-202.
22. Klomp HM, Spincemaille GH, Steyerberg EW, Habbema JD, van Urk H. Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet. 1999;353:1040-1044.
23. Spincemaille GH, de Vet HC, Ubbink DT, Jacobs MJ. The results of spinal cord stimulation in critical limb ischaemia: a review. Eur J Vasc Endovasc Surg. 2001;21:99-105.
24. Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg. 2003;26:280-286.
25. Augustinsson LE, Carlsson CA, Holm J, Jivegard L. Epidural electrical stimulation in severe limb ischemia. Pain relief, increased blood flow, and a possible limb-saving effect. Ann Surg. 1985;202:104-110.
26. Broseta J, Barbera J, de Vera JA, et al. Spinal cord stimulation in peripheral arterial disease. A cooperative study. J Neurosurg. 1986;64:71-80.
27. van Eijs F, Stanton-Hicks M, Van Zundert J, et al. 16. Complex regional pain syndrome. Pain Pract. 2011;11:70-87.
28. Matsumoto Y, Ueyama T, Endo T, et al. Endoscopic thoracic sympathicotomy for Raynaud's phenomenon. J Vasc Surg. 2002;36:57-61.
29. Maga P, Kuzdzal J, Nizankowski R, Szczeklik A, Sladek K. Long-term effects of thoracic sympathectomy on microcirculation in the hands of patients with primary Raynaud disease. J Thorac Cardiovasc Surg. 2007;133:1428-1433.
30. Thune TH, Ladegaard L, Licht PB. Thoracoscopic sympathectomy for Raynaud's phenomenon-a long term follow-up study. Eur J Vasc Endovasc Surg. 2006;32:198-202.
31. Van Beek AL, Lim PK, Gear AJ, Pritzker MR. Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg. 2007;119:217-226.